Prediction of clinical relapse by NBI-CAD in patients with ulcerative colitis.

Prediction of clinical relapse by NBI-CAD in patients with ulcerative colitis. - UC relapse prediction by NBI-CAD

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000046101

Enrollment

100

Registered

2021-12-01

Start date

2021-11-17

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ulcerative colitis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with a definite diagnosis of ulcerative colitis in advance Patients undergoing lower gastrointestinal endoscopy due to clinical need Clinical remission Endoscopic remission Patients who have not used prednisolone within 6 months Patients with no history of radiation therapy for the abdomen or pelvis

Exclusion criteria

Exclusion criteria: Patients who have been asked to refuse to participate in this study Patients who could not be followed up at the end of the study or until relapse

Design outcomes

Primary

Measure	Time frame
UC-CAD clinical relapse rate by diagnosis(12 month).	—

Countries

Japan

Contacts

Public ContactYasuharu Maeda

Showa University Northern Yokohama Hospital Digestive Disease Center

yasuharumaeda610@hotmail.com09097786308

Outcome results